-
In this issue: ACEI/ARB therapy for AS; safety alert issued for dronedarone; statins and cancer risk; nesiritide and heart failure; and FDA actions.
-
-
"Sand; tiny, discrete particles with substance but basically without fixed structure, frequently accumulating in forms of great beauty or built into 'castles.' In this elemental form sand, and data, present great danger, able to blind us or even bury us." Walter J Hierholzer, Jr., MD
-
Katrina Crist, MBA, was recently named the new chief executive officer at the Association for Professionals in Infection Control & Epidemiology in Washington, DC.
-
With pathogens like Clostridium difficile and multidrug-resistant Acinebactor which can linger on surfaces and fomites for prolonged periods the health care environment is among the top priority research areas to prevent health care associated infections (HAIs).
-
Having finally wrested a seat at the C-suite table, infection preventionists are now poised to move to the patient bedside. A profession that has labored in relative obscurity for much of its existence is at a critical juncture with a host of influential agents who are suddenly very interested in infection prevention: patients, consumer advocates, state and federal regulators. A path to empowerment has opened.
-
When a single imported case of measles led to a small outbreak in Tucson, AZ, in 2008, two hospitals were forced to spend a total of some $800,000 to contain it, much of that related to ensuring the immunity of employees.
-
A consortium of 10 pediatric hospitals in Bangladesh, Egypt, Malawi, Pakistan, and Vietnam was assembled by the World Health Organization CSF5 study group with funding from the U.S. Agency for International Development to compare 5 days vs. 10 days of therapy with ceftriaxone.
-
The United States Perinatal HIV Surveillance Project tracks HIV-infected pregnant women in care in 15 locations throughout the United States and Puerto Rico.
-
By 2007, the prevalence of fluoroquinolone resistance among N. gonorrhoeae had become so widespread in the United States that the CDC recommended against use of drugs of that class in the treatment of gonorrhea.
